Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): Estimation of the rate of factor VIIIC synthesis

British Journal of Haematology

Volumn 94, Issue 4, 1996, Pages 740-745

  Menache, Doris ^a   Aronson, David L ^b   Darr, Fred ^a   Montgomery, Robert R ^c   Gill, Joan C ^d   Kessler, Craig M ^d   Lusher, Jeanne M ^d   Phatak, Pradyumna D ^d   Shapiro, Amy D ^d   Thompson, Arthur R ^d   White II, Gilbert C ^d  

^a AMERICAN RED CROSS   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d NONE

Author keywords

Bleeding time; Factor; Rate of FVIIC synthesis; VIIIC; VWF

Indexed keywords

BLOOD CLOTTING FACTOR 8; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLEEDING TIME; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

EID: 9544220778     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1860.x     Document Type: Article

References (23)

1. Bennett, B., Ratnoff, O.D. & Levin, J. (1972) Immunologic studies in von Willebrand's disease: evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia. Journal of Clinical Investigation, 51, 2597-2601.
2. Biggs, R. & Matthews, J.M. (1963) The treatment of haemorrhage in von Willebrand's disease and the blood level of factor VIII (AHG). British Journal of Haematology, 9, 203-214.
3. Bjorkman, S., Carlsson, M., Berntorp, E. & Stenberg, P. (1992) Pharmocokinetics of factor VIII in humans: obtaining clinically relevant data from comparative studies. Clinical Pharmacokinetics, 22, 385-395.
4. Burnouf-Radosevich, M. & Burnouf, T. (1992) Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate. Vox Sanguinis, 62, 1-11.
5. Cornu, P., Larrieu, M.J., Caen, J. & Bernard, J. (1963) Transfusion studies in von Willebrand's disease: effect on bleeding time and factor VIII. British Journal of Haematology, 9, 189-201.
6. Goudemand, J., Mazurier, C., Marey, A., Caron, C., Coupez, B., Mizon, P. & Goudemand, M. (1992) Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity. British Journal of Haematology, 80, 214-221.
7. Howard, M.A., Sawyers, R.J. & Firkin, B.G. (1973) Ristocetin: a means of differentiating von Willebrand's disease into two groups. Blood, 41, 687-690.
8. Kasper, C.K., Kim, H.C., Gomperts, E.D., Smith, K.J., Salzman, P.M., Tipping, D., Miller, R. & Montgomery, R.R. (1991) In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates. Thrombosis and Haemostasis, 66, 730-733.
9. Kernoff, P.B.A., Rizza, C.R. & Kaelin, A.C. (1974) Transfusion and gel filtration studies in von Willebrand's disease. British Journal of Haematology, 28, 357-370.
10. Lethagen, S., Berntorp, E. & Nilsson, I.M. (1992) Pharmacokinetics and hemostatic effect of different factor VII/von Willebrand factor concentrates in von Willebrand's disease type III. Annals of Hematology, 65, 253-259.
11. Mannucci, P.M., Tenconi, P.M., Castaman, G. & Rodeghiero, F. (1992) Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial. Blood, 79, 3130-3137.
12. Mazurier, C., Jorieux, S., de Romeuf, C., Samor, B. & Goudemand, M. (1991) In vitro evaluation of a very-high-purity, solvent/detergent-treated, von Willebrand factor concentrate. Vox Sanguinis, 61, 1-7.
13. McCarroll, D.R., Ruggeri, Z.M. & Montgomery, R.R. (1984) Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease. Journal of Laboratory and Clinical Medicine, 103, 704-711.
14. Meriane, F., Zerhouni, L., Djeha, N., Goudemand, M. & Mazurier, C. (1993) Biological effects of a S/D-treated, very high purity, von Willebrand factor concentrate in five patients with severe von Willebrand disease. Blood Coagulation and Fibrinolysis, 4, 1023-1029.
15. Montgomery, R.R., Hathaway, W.E., Johnson, J., Jacobson, L. & Muntean, W. (1982) A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood, 60, 201-207.
16. Morfini, M., Mannucci, P.M., Tenconi, P.M., Longo, G., Mazzucconi, M.G., Rodeghiero, F., Ciavarella, N., De Rosa, V. & Arter, A. (1993) Pharmacokinetics of monoclonally-purified and recombinant factor VIII in patients with severe von Willebrand disease. Thrombosis and Haemostasis, 70, 270-272.
17. Nilsson, I.M., Blombäck, M. & Blombäck, B. (1960) The use of human anti-haemophilic globulin (fraction I-O) in haemophilia A and in von Willebrand's disease. Acta Haematologica, 24, 116-123.
18. Schwartz, R.S., Abildgaard, C.F., Aledort, L.M., Arkin, S., Bloom, A.L., Brackmann, H.H., Brettler, D.B., Fukui, H., Hilgartner, M.W., Inwood, M.J., Kasper, C.K., Kernoff, P.B.A., Levine, P.M., Lusher, J.M., Mannucci, P.M., Scharrer, I., MacKenzie, M.A., Pancham, N., Kuo, H.S., Allred, R.U., and the Recombinant Factor VIII Study Group (1990) Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. New England Journal of Medicine, 323, 1800-1805.
19. Schullek, J., Jordan, J. & Montgomery, R.R. (1984) Interaction of von Willebrand factor with human platelets in the plasma milieu. Journal of Clinical Investigation, 73, 421-428.
20. Simone, J.V., van der Heiden, J. & Abildgaard, C.F. (1967) A semiautomatic one-stage factor VIII assay with a commercially prepared standard. Journal of Laboratory and Clinical Medicine, 69, 706-712.
21. Tuddenham, E.G.D., Lane, R.S., Rotblat, F., Johnson, A.J., Snape, T.J., Middleton, S. & Kernoff, P.B.A. (1982) Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease. British Journal of Haematology, 52, 259-267.
22. Weiss, H.J. (1974) Relation of von Willebrand factor to bleeding time. (Letter). New England Journal of Medicine, 291, 420.
23. White, G.C., McMillan, C.W., Kingdon, H.S. & Shoemaker, C.B. (1989) Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia. New England Journal of Medicine, 320, 166-170.